FDA Approves Dupilumab for Children With Eosinophilic Esophagitis
Approval is for children ages 1 to 11 years, weighing at least 15 kg
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Approval is for children ages 1 to 11 years, weighing at least 15 kg
Only registered members have full access to PracticeUpdate content.